diabetic%20ketoacidosis%20-and-%20hyperosmolar%20hyperglycemic%20state
DIABETIC KETOACIDOSIS & HYPEROSMOLAR HYPERGLYCEMIC STATE
Diabetic ketoacidosis is characterized by having blood glucose >13.9 mmol/L, arterial pH <7.3 in adults or venous pH <7.3 in pediatrics, bicarbonate <15 mEg/L, moderate ketonuria or ketonemia and anion gap >14.
Hyperosmolar hyperglycemic state in adults is described as having blood glucose >33.3 mmol/L, arterial pH >7.3, bicarbonate >15 mEq/L, mild ketonuria or ketonemia, effective serum osmolality >320 mOsm/kg and variable anion gap.
Hyperosmolar hyperglycemic state in pediatric patients has blood glucose >33.3 mmol/L, venous pH >7.3, bicarbonate >15 mEq/L and altered mental status or severe dehydration.

Pharmacotherapy

  • DKA & HHS patients are best managed in the intensive care unit w/ the care of a specialist/endocrinologist

Intravenous (IV) Fluids

  • Initial therapy aims to restore renal perfusion, & expand intravascular & extravascular volume
  • Fluid deficits should be corrected w/in the first 24 hours of treatment
  • Serum Na should be corrected for hyperglycemia (for each 5.6 mmol/L glucose >5.6 mmol/L, add 1.6 mmol to Na value for corrected serum Na value)
  • Serum osmolality change should not be >3 mOsm/kg H2O/hour
  • Avoid iatrogenic fluid overload by frequently monitoring cardiac, renal & mental status
  • In pediatric patients, initial fluid expansion should not be >50 mL/kg over first 4 hours of treatment
    • Fluid deficits should be corrected over 48 hours of treatment

Insulin

  • Ketonemia usually takes longer to clear than hyperglycemia
  • May or may not be aggressive w/ insulin administration depending on patient hydration
  • If patient presents w/ severe hypokalemia, insulin treatment should be delayed until K serum concentration is restored to >3.3 mmol/L to avoid respiratory arrest & arrhythmias
  • There should be an overlap of IV insulin & subcutaneous (SC) insulin of 1-2 hours to ensure adequate glucose control
    • An abrupt discontinuation of IV insulin w/ a delayed onset of SC insulin may result in inadequate glucose control
  • In newly diagnosed diabetics the initial total insulin dose should be ~0.5-1 U/kg/day given in ≥2 divided doses
    • Include both short-acting & long-acting insulin
    • Continue until optimal dosing is established

Potassium

  • Correction of acidosis, volume expansion & insulin therapy decrease serum K concentration
    • Hypokalemia may be avoided by K replacement 

Bicarbonate

  • Studies have failed to show benefit or deleterious changes in morbidity or mortality w/ bicarbonate use in diabetic ketoacidosis (DKA) patients w/ pH between 6.9-7.1
  • Insulin & bicarbonate can lower serum K & supplementation may be required

Phosphate

  • Patients w/ cardiac dysfunction, anemia or respiratory depression may benefit from careful phosphate replacement
    • Hypophosphatemia may cause cardiac & skeletal muscle weakness, & respiratory depression

Somatostatin

  • Though not considered standard therapy, Somatostatin may be added if patients are resistant to conventional DKA therapy
  • Effects: Decrease glucagon secretion & inhibit ketogenesis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 28 Nov 2017
A dietary pattern rich in fresh and dried fruits, nuts and seeds, vegetable oils, and low-fat dairy products appears to lower the incidence rate of insulin resistance, according to an Iran study.
Pearl Toh, 20 Apr 2018
The investigational oral synthetic androgen dimethandrolone undecanoate (DMAU) suppresses serum testosterone levels to near castrate levels and appears safe when taken once daily for a month, showing potential as a male contraceptive pill, according to a study.
02 Aug 2018
Men and women who regularly eat seafood appear to have higher sexual intercourse frequency (SIF) and fecundity in a large prospective cohort of couples attempting pregnancy, suggests a study.
12 Apr 2018
In the context of low-glycaemic index (GI) dietary patterns, eating pasta does not contribute to adiposity and may even reduce body weight and body mass index (BMI) compared with higher-GI dietary patterns, a recent study has found.